Navigation Links
ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
Date:12/3/2008

RANCHO CORDOVA, Calif., Dec. 3 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that it will hold a conference call on Thursday, December 4, to discuss its announcement regarding a management transition at the Company.

The conference call will begin at 5:30 a.m., Pacific Standard Time (8:30 a.m., Eastern Standard Time). The call can be accessed by calling (800) 860-2422 (domestic) or (412) 858-4600 (international), passcode ThermoGenesis. The webcast will also be available on the Company's website at http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

A replay of the call will be available by calling (877) 344-7529 (domestic), or (412) 317-0088 (international), passcode 385107#, or via the Company's website.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.

This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

     ThermoGenesis Corp.
     Web site:http://www.thermogenesis.com
     Contact: Investor Relations
     +1-916-858-5107, or
     ir@thermogenesis.com

'/>"/>
SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
2. ThermoGenesis Reports First Quarter 2009 Results
3. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
4. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
5. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
6. ThermoGenesis Corp. Reports First Quarter 2008 Results
7. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
8. Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2008
9. HMS Holdings Corp. To Present at The 20th Annual Piper Jaffray Healthcare Conference
10. Escalon(R) Medical Corp. Completes $1.1 Million Private Equity Financing
11. HMS Holdings Corp. to Present at Stephens Inc. Fall Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... MD (PRWEB) , ... January 17, 2017 , ... SC&H ... the firm as a Principal in its IT Advisory Services practice . Rossi ... recent months as market demand for strategic IT guidance grows, and the practice continues ...
(Date:1/17/2017)... ... January 17, 2017 , ... Seceon , the ... in real-time, today announced a strategic partnership with TechLab Security, a ... Seceon partners, TechLab Security has become a strategic partner and a value added ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers Agency, a ... the latest beneficiary of their thriving community involvement program. The current campaign fundraises ... the dreams of terminally ill patients. Donations to this worthy cause may now ...
(Date:1/17/2017)... ... ... people make New Year’s resolutions or renew their commitment to better health with the start ... who want to kick off 2017 with better smiles. Dr. Mondavi is offering several promotions ... include: , , A new patient package for just $49, which ...
(Date:1/17/2017)... ... January 17, 2017 , ... Twelve ... State University’s Athletic Training Education program forged a relationship built upon the foundation ... Program, which is consists of both student members and certified members of the ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017  OrthoAccel ® Technologies, ... (JCO) has published "The Effect of Vibration on ... Conducted by Dr. S. Jay Bowman , this ... II malocclusions, AcceleDent,s SoftPulse Technology ® speeds up ... also reducing the number of days to move the ...
(Date:1/17/2017)... , Jan 17, 2017 Research and Markets ... Healthcare Industry 2016-2020" report to their offering. ... The global fluoropolymer market in ... the period 2016-2020. Global Fluoropolymer Market in the ... analysis with inputs from industry experts. The report covers the market ...
(Date:1/17/2017)... 2017 Following an initial analysis, the ... Food and Drug Administration,s (FDA,s) final regulatory guidance ... by Pharmacies and Outsourcing Facilities." In its final ... pre-packaging -- which would have put patients at ... term care (LTC) pharmacies.  The ...
Breaking Medicine Technology: